Thomas S. K. Gilbert

University of North Carolina (UNC) at Chapel Hill - Department of Pharmacology

102 Ridge Road

Chapel Hill, NC 27514

United States

SCHOLARLY PAPERS

2

DOWNLOADS

101

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (2)

1.

KRAS Suppression-Induced Degradation of MYC is Antagonized by a MEK5-ERK5 Compensatory Mechanism

Number of pages: 80 Posted: 12 Apr 2018
University of North Carolina (UNC) at Chapel Hill - Lineberger Comprehensive Cancer Center, University of North Carolina (UNC) at Chapel Hill - Department of Pharmacology, University of North Carolina (UNC) at Chapel Hill - Department of Pharmacology, Translational Genomic Research Institute - Molecular Medicine Division, Van Andel Institute - Pathology and Biorepository Core, University of North Carolina (UNC) at Chapel Hill - Curriculum in Genetics and Molecular Biology, University of Helsinki - Institute for Molecular Medicine Finland (FIMM), University of North Carolina (UNC) at Chapel Hill - Lineberger Comprehensive Cancer Center, University of North Carolina (UNC) at Chapel Hill - Center for Integrative Chemical Biology and Drug Discovery, University of North Carolina (UNC) at Chapel Hill - Department of Pharmacology, Translational Genomic Research Institute - Molecular Medicine Division, University of North Carolina (UNC) at Chapel Hill - Lineberger Comprehensive Cancer Center, University of Arizona - Department of Medicine, University of Arizona - Department of Medicine, University of North Carolina (UNC) at Chapel Hill - Lineberger Comprehensive Cancer Center, University of North Carolina (UNC) at Chapel Hill - Lineberger Comprehensive Cancer Center, University of Texas at San Antonio, Health Science Center, Greehey Children's Cancer Research Institute, University of Helsinki - Institute for Molecular Medicine Finland (FIMM), University of North Carolina (UNC) at Chapel Hill - Lineberger Comprehensive Cancer Center and University of North Carolina (UNC) at Chapel Hill - Lineberger Comprehensive Cancer Center
Downloads 65 (622,699)

Abstract:

Loading...

2.

Targeting P130Cas- and Microtubule-Dependent MYC Regulation Sensitizes Pancreatic Cancer to ERK MAPK Inhibition

Number of pages: 102 Posted: 01 Sep 2020
University of North Carolina (UNC) at Chapel Hill - School of Medicine, University of North Carolina (UNC) at Chapel Hill - Lineberger Comprehensive Cancer Center, University of North Carolina (UNC) at Chapel Hill - Lineberger Comprehensive Cancer Center, University of North Carolina (UNC) at Chapel Hill - Lineberger Comprehensive Cancer Center, University of North Carolina (UNC) at Chapel Hill - Lineberger Comprehensive Cancer Center, University of North Carolina (UNC) at Chapel Hill - Curriculum in Genetics and Molecular Biology, Broad Institute of MIT and Harvard, Broad Institute of MIT and Harvard, Broad Institute of MIT and Harvard, Broad Institute of MIT and Harvard, University of North Carolina (UNC) at Chapel Hill - Department of Pharmacology, University of North Carolina (UNC) at Chapel Hill - Lineberger Comprehensive Cancer Center, University of North Carolina (UNC) at Chapel Hill - Oral and Craniofacial Biomedicine PhD Program, Oslo University Hospital, University of North Carolina (UNC) at Chapel Hill - Department of Nutrition, University of North Carolina (UNC) at Chapel Hill - Department of Pharmacology, University of North Carolina (UNC) at Chapel Hill - Lineberger Comprehensive Cancer Center, University of North Carolina (UNC) at Chapel Hill - Department of Pharmacology, University of North Carolina (UNC) at Chapel Hill - Lineberger Comprehensive Cancer Center, University of North Carolina (UNC) at Chapel Hill - Curriculum in Genetics and Molecular Biology, Translational Genomic Research Institute - Cancer and Cell Biology Division, Translational Genomic Research Institute - Cancer and Cell Biology Division, Genomics Institute of the Novartis Research Foundation, Genomics Institute of the Novartis Research Foundation, Genomics Institute of the Novartis Research Foundation, University of North Carolina (UNC) at Chapel Hill - Department of Pharmacology, University of North Carolina (UNC) at Chapel Hill - Lineberger Comprehensive Cancer Center, Translational Genomic Research Institute - Cancer and Cell Biology Division, Broad Institute of MIT and Harvard, Broad Institute of MIT and Harvard, University of North Carolina (UNC) at Chapel Hill - Lineberger Comprehensive Cancer Center and University of North Carolina (UNC) at Chapel Hill - Lineberger Comprehensive Cancer Center
Downloads 36 (801,551)

Abstract:

Loading...

BCAR1, ERK, KRAS, microtubules, MYC, p130Cas, pancreatic cancer, SRC, TUBB3, betaIII-tubulin